Arkema (OTCMKTS:ARKAY – Get Free Report) is projected to issue its results before the market opens on Thursday, February 26th. Analysts expect the company to announce earnings of $0.53 per share for the quarter.
Arkema Price Performance
Shares of OTCMKTS ARKAY opened at $70.36 on Tuesday. The company has a market capitalization of $5.35 billion, a PE ratio of 33.83, a PEG ratio of 1.45 and a beta of 0.90. The company has a quick ratio of 2.26, a current ratio of 3.07 and a debt-to-equity ratio of 0.55. The stock’s 50 day moving average price is $64.09 and its 200-day moving average price is $63.93. Arkema has a twelve month low of $56.28 and a twelve month high of $91.51.
Analysts Set New Price Targets
ARKAY has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft cut Arkema from a “buy” rating to a “hold” rating in a research report on Monday, November 24th. Barclays downgraded shares of Arkema from a “hold” rating to a “strong sell” rating in a report on Tuesday, November 11th. The Goldman Sachs Group upgraded shares of Arkema from a “hold” rating to a “buy” rating in a research report on Tuesday, February 10th. Finally, Zacks Research lowered shares of Arkema from a “hold” rating to a “strong sell” rating in a research report on Tuesday, January 6th. Two investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Reduce”.
About Arkema
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Featured Articles
- Five stocks we like better than Arkema
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Silver $500? The “Deficit Math” says it’s possible.
- Elon Musk: This Could Turn $100 into $100,000
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
